Korean Circ J.  2001 Jan;31(1):24-30. 10.4070/kcj.2001.31.1.24.

Long-term Clinical and Angiographic Results of Coronary Stenting in Diabetic Patients

• Kim W
• Jeong MH
• Kim KH
• Park JC
• Lee SH
• Rue JY
• Kang KT
• Ahn YK
• Cho JG
• Park JC
• Kang JC

• KMID: 2029532
• DOI: http://doi.org/10.4070/kcj.2001.31.1.24

Abstract

BACKGROUND: Diabetes is a major risk factor for restenosis and high mortality after percutaneous coronary intervention. The impact of coronary stenting on the clinical outcome of diabetic patients remains controversial. METHOD: The in-hospital and long-term clinical outcomes of 104 consecutive diabetic (60+/-8 year-old, 74 male) and age-matched 193 control (57+/-10 year-old, 162 male) patents underwent coronary stenting between January 1998 and March 1999 at Chonnam National University Hospital were compared.
RESULTS
1) Coronary stenting was successful in 98% of diabetic patients and 97% of non-diabetic patients. Post-procedural minimal luminal diameter (MLD) was not different between two groups(2.89+/-0.42 vs. 2.95+/-0.62 mm), but follow-up MLD was lower in diabetics than that in non-diabetics (1.70+/-0.96 vs. 2.05+/-0.72 mm, P < 0.05). 2) Restenosis rate on follow-up coronary angiograpy was not different between two groups (40.7% in diabetics and 32.0% in non-diabetics. 3) In-hospital outcome was not different between two groups. Long-term clinical follow-up (16+/-11 months) revealed higher overall major adverse cardiac events in diabetics than in non-diabetics (38.7 vs. 30.7 %, P < 0.05).
CONCLUSION
Coronary stenting in diabetics can be performed with acceptable short-term results. However, long-term clinical outcome in diabetic patients was worse than in non-diabetics.

MeSH Terms

Follow-Up Studies
Humans
Jeollanam-do
Mortality
Percutaneous Coronary Intervention
Phenobarbital
Risk Factors
Stents*
Phenobarbital